Over the past 12 months, 0 insiders at Vigil Neuroscience, Inc. filed 0 open-market SEC Form 4 transactions on VIGL: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 19, 24 | Budd Haeberlein Samantha L.Director | BUY | 12.0K | $1.71 | $21K |
| Dec 19, 24 | Ivana Magovcevic-liebischPresident and CEO | BUY | 5.0K | $1.68 | $8K |
| Dec 18, 24 | Ivana Magovcevic-liebischPresident and CEO | BUY | 5.0K | $1.67 | $8K |
| Dec 5, 24 | Ivana Magovcevic-liebischPresident and CEO | BUY | 5.0K | $2.34 | $12K |
| Nov 20, 23 | Ivana Magovcevic-liebischPresident and CEO | BUY | 4.0K | $3.75 | $15K |
| Nov 18, 22 | Spyros PapapetropoulosChief Medical Officer | SELL | 300 | $14.00 | $4K |
| May 17, 22 | Clay ThorpDirector | BUY | 14.9K | $2.97 | $44K |
| May 16, 22 | Clay ThorpDirector | BUY | 21.8K | $2.76 | $60K |
| May 5, 22 | Evan ThackaberrySVP, Head of Early Development | BUY | 1.5K | $4.00 | $6K |
| May 3, 22 | Spyros PapapetropoulosChief Medical Officer | BUY | 4.0K | $3.40 | $14K |
| May 3, 22 | Christopher VerniGeneral Counsel | BUY | 4.0K | $3.77 | $15K |
| May 3, 22 | Jennifer Lynn ZiolkowskiChief Financial Officer | BUY | 4.0K | $3.77 | $15K |
| May 3, 22 | Ivana Magovcevic-liebischPresident and CEO | BUY | 1.0K | $3.94 | $4K |
| May 2, 22 | Ivana Magovcevic-liebischPresident and CEO | BUY | 4.0K | $3.61 | $14K |
| Mar 28, 22 | Clay ThorpDirector | BUY | 3.0K | $7.20 | $22K |
| Jan 11, 22 | Atlas Venture Opportunity Fund I, L.p.TenPercentOwner | BUY | 535.0K | $14.00 | $7.5M |
| Jan 11, 22 | Bruce BoothDirector | BUY | 535.0K | $14.00 | $7.5M |
| Jan 11, 22 | Northpond Ventures, LpTenPercentOwner | BUY | 355.0K | $14.00 | $5.0M |
| Jan 11, 22 | Clay ThorpDirector | BUY | 265.0K | $14.00 | $3.7M |
| Jan 11, 22 | Vida Ventures Gp Iii, L.l.c.TenPercentOwner | BUY | 1.67M | $14.00 | $23.4M |
| Jan 11, 22 | Stefan VitorovicDirector | BUY | 1.67M | $14.00 | $23.4M |
Over the past 12 months, insiders at Vigil Neuroscience, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on VIGL, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market VIGL insider purchase in our data was $23.4M by Vida Ventures Gp Iii, L.l.c., TenPercentOwner, filed on Jan 11, 22.
0 different insiders at Vigil Neuroscience, Inc. filed open-market SEC Form 4 transactions on VIGL over the last 12 months.
InsiderTape plots every VIGL insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Vigil Neuroscience, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →